echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Synthetic Routes of Pirarubicin

    The Synthetic Routes of Pirarubicin

    • Last Update: 2023-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pirarubicin is a widely used anticancer drug that belongs to the group of anthracyclines.
    The chemical synthesis of pirarubicin has been a subject of extensive research in the chemical industry due to its complex structure and challenging synthesis route.
    Over the years, different synthetic routes have been developed to synthesize pirarubicin, and in this article, we will discuss some of the most commonly used synthetic routes for pirarubicin.


    One of the most common routes for the synthesis of pirarubicin is through the reaction of rubber with a variety of alkylating agents such as phenylchloride, methyl iodide, or ethyl bromide.
    This reaction results in the formation of a rubber-alkylating agent adduct, which is then reduced to form the final product.
    This synthesis route is relatively simple and widely used in the industry.


    Another commonly used route for the synthesis of pirarubicin is through the reaction of tall oil with chlorpromazine in the presence of a solvent such as acetone or benzene.
    This reaction results in the formation of an intermediate compound, which is then further transformed into pirarubicin through a series of chemical reactions.


    A more recent synthetic route for pirarubicin involves the synthesis of the natural product precursor, anthraquinone-2-carboxylic acid, through the reaction of 2,5-dimethoxyfuran with salicylic aldehyde in the presence of a base such as sodium hydroxide.
    This intermediate compound is then transformed into pirarubicin through a series of chemical reactions.


    In addition to the above-mentioned synthetic routes, pirarubicin can also be synthesized through a variety of other routes such as the use of microbial fermentation, the enzymatic synthesis of its natural precursor, and the synthesis of its semisynthetic analogs.


    One of the main advantages of the synthetic routes for pirarubicin is that they allow for the large-scale production of this important anticancer drug.
    This is critical for meeting the demand for the drug in the pharmaceutical industry and ensuring that it is available to patients who require it.


    In addition to its use in the pharmaceutical industry, pirarubicin is also used in research and development for the study of its structure and properties, as well as for the development of new and more effective anticancer drugs.


    Overall, the synthetic routes for pirarubicin are diverse and have been developed over many years of research and development in the chemical industry.
    These routes allow for the large-scale production of this important anticancer drug and have played an essential role in its widespread use in the pharmaceutical industry.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.